my $400-$450 price target seeming more and more possible as we go.
If Zantrene can synergize will of of these different Cancer Drugs, then we won't even need to sell the Drug, just sell the rights to be able to use in Reformulation of existing drugs, which will then extend Those existing Drug patents, PLUS Increase Efficiency, PLUS decrease Cardiotoxicity concerns.
Why sell to 1, when you can license to ALL!!
my $400-$450 price target seeming more and more possible as we...
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.23 |
Change
-0.025(1.99%) |
Mkt cap ! $205.2M | |||
| Open | High | Low | Value | Volume |
| $1.26 | $1.26 | $1.23 | $47.71K | 38.47K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 3274 | $1.23 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.24 | 1200 | 1 |
View Market Depth
| Last trade - 11.05am 01/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.23 |
Change
-0.025 ( 2.38 %) |
||||
| Open | High | Low | Volume | ||
| $1.25 | $1.25 | $1.23 | 4817 | ||
| Last updated 11.23am 01/05/2024 ? | |||||
| RAC (ASX) Chart |